Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.
Department of Dermatology, Columbia University, New York, NY, USA.
Ali
0000-0002-8559-7314
A
Jabbari
Department of Dermatology, Columbia University, New York, NY, USA.
Nhan
N
Nguyen
Department of Dermatology, Columbia University, New York, NY, USA.
Jane E
JE
Cerise
Department of Dermatology, Columbia University, New York, NY, USA.
Grace
G
Ulerio
Department of Dermatology, Columbia University, New York, NY, USA.
Annemieke
A
de Jong
Department of Dermatology, Columbia University, New York, NY, USA.
Raphael
R
Clynes
Department of Dermatology, Columbia University, New York, NY, USA.
Angela M
AM
Christiano
Department of Dermatology, Columbia University, New York, NY, USA.
Julian
J
Mackay-Wiggan
D000328:Adult; D000506:Alopecia Areata / Q000097:blood / Q000188:drug therapy*; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D011758:Pyrroles / Q000494:pharmacology / Q000627:therapeutic use*; D012867:Skin / Q000187:drug effects / Q000378:metabolism
D015415:Biomarkers; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011758:Pyrroles; C479163:tofacitinib
JAK inhibitors; alopecia areata; biomarkers; tofacitinib